Achieve Life Sciences Reports Q2 2026 Financial Results

What Happened
Achieve Life Sciences, Inc. (ACHV) filed a Form 8‑K on August 11, 2026 (Item 2.02) announcing its results of operations and financial condition for the second quarter ended June 30, 2026. The company issued a press release with the quarterly financial results, which is furnished as Exhibit 99.1 to the 8‑K.

Key Details

• Form 8‑K filed on August 11, 2026 reporting quarterly results (Item 2.02).
• Results cover the quarter ended June 30, 2026 (Q2 2026).
• Press release of financial results is attached as Exhibit 99.1 to the filing.
• The filing also includes the Inline XBRL cover page (Exhibit 104).

Why It Matters
This filing is the company’s official public disclosure of its quarterly earnings and financial condition. Retail investors should read the attached press release (Exhibit 99.1) for concrete figures—revenue, net income/loss, cash position and any commentary on operations or guidance—as those items can influence share price and investment decisions.